These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2574906)
1. Increased serum pepsinogen I and recurrence of duodenal ulcer. Sumii K; Inbe A; Uemura N; Kimura M; Haruma K; Yoshihara M; Teshima H; Kajiyama G; Miyoshi A Scand J Gastroenterol; 1989 Dec; 24(10):1200-4. PubMed ID: 2574906 [TBL] [Abstract][Full Text] [Related]
2. Serum pepsinogen values as possible markers for evaluating the possibility of peptic ulcer recurrence under H2-blocker half-dose maintenance therapy. Matsushima M; Miki K; Ichinose M; Kakei N; Yahagi N; Kido M; Shimizu Y; Ishihama S; Tsukada S; Kurokawa K Adv Exp Med Biol; 1995; 362():131-7. PubMed ID: 8540311 [No Abstract] [Full Text] [Related]
3. Helicobacter pylori infection and serum pepsinogen I concentration in peptic ulcer patients: effect of bacterial eradication. Park SM; Park J; Chang SK; Yoo BC; Kim HJ Korean J Intern Med; 1996 Jan; 11(1):1-8. PubMed ID: 8882471 [TBL] [Abstract][Full Text] [Related]
4. Duodenal ulcer is a multifactorial disorder--the role of pepsinogen I. Chang FY; Lai KH; Wang TF; Lee SD; Tsai YT S Afr Med J; 1993 Apr; 83(4):264-6. PubMed ID: 8316925 [TBL] [Abstract][Full Text] [Related]
5. Recurrence of duodenal ulcer and elevated serum pepsinogen I levels in smokers and nonsmokers. Sumii K; Kimura M; Morikawa A; Haruma K; Yoshihara M; Kajiyama G Am J Gastroenterol; 1990 Nov; 85(11):1493-7. PubMed ID: 2239877 [TBL] [Abstract][Full Text] [Related]
6. Effect of Helicobacter pylori on serum pepsinogen I and plasma gastrin in duodenal ulcer patients. Chittajallu RS; Dorrian CA; Ardill JE; McColl KE Scand J Gastroenterol; 1992; 27(1):20-4. PubMed ID: 1736337 [TBL] [Abstract][Full Text] [Related]
7. Serum group I pepsinogen (PG I) levels and their changes in the healing process of the ulcer in patients with and without unoperated recurrent ulcer. Nakanome C; Yamazaki H; Tanno N; Sasaki M; Sato W; Hanada M; Moriai N; Komatsu K Tohoku J Exp Med; 1984 Jun; 143(2):239-48. PubMed ID: 6474453 [TBL] [Abstract][Full Text] [Related]
8. Serum pepsinogen I and pepsinogen II, and the ratio of pepsinogen I/pepsinogen II in peptic ulcer diseases: with special emphasis on the influence of the location of the ulcer crater. Wu MS; Wang HP; Wang JT; Wang TH; Lin JT J Gastroenterol Hepatol; 1995; 10(4):401-4. PubMed ID: 8527705 [TBL] [Abstract][Full Text] [Related]
9. [Sulglycotide combined with H2-antagonists in the prevention of duodenal ulcer recurrence. Multicenter study]. Ciaco A; Papi C; Capurso L Minerva Gastroenterol Dietol; 1992; 38(3):153-9. PubMed ID: 1363719 [TBL] [Abstract][Full Text] [Related]
10. Verification of decreased basal and stimulated serum pepsinogen-I levels is a useful non-invasive method for determining the success of eradication therapy for Helicobacter pylori. Gisbert JP; Boixeda D; Vila T; de Rafael L; Redondo C; Cantón R; Martín de Argila C Scand J Gastroenterol; 1996 Feb; 31(2):103-10. PubMed ID: 8658030 [TBL] [Abstract][Full Text] [Related]
11. A cost analysis of alternative treatments for duodenal ulcer. Imperiale TF; Speroff T; Cebul RD; McCullough AJ Ann Intern Med; 1995 Nov; 123(9):665-72. PubMed ID: 7574221 [TBL] [Abstract][Full Text] [Related]
12. Recurrence of duodenal ulcer under continuous antisecretory treatment: an approach to the detection of predictive markers. Battaglia G; Farini R; Di Mario F; Piccoli A; Plebani M; Vianello F; Burlina A; Naccarato R Am J Gastroenterol; 1984 Nov; 79(11):831-4. PubMed ID: 6095649 [TBL] [Abstract][Full Text] [Related]
13. Influence of RP 40749 on basal and meal-stimulated serum-gastrin, serum-pepsinogen I, and gastrin-content of the antral mucosa in duodenal ulcer patients. Nelis GF; Lamers CB; Pals G Dig Dis Sci; 1985 Jul; 30(7):617-23. PubMed ID: 4006644 [TBL] [Abstract][Full Text] [Related]
14. Serum pepsinogen I levels of gastric ulcer patients are determined by the location of the ulcer crater. Chang FY; Lai KH; Wang TF; Lee FY; Lee SD; Tsai YT Gastroenterol Jpn; 1992 Feb; 27(1):9-14. PubMed ID: 1555752 [TBL] [Abstract][Full Text] [Related]
15. Effect of eradication of Helicobacter pylori on serum pepsinogen I, gastrin, and insulin in duodenal ulcer patients: a 12-month follow-up study. Chen TS; Tsay SH; Chang FY; Lee SD Am J Gastroenterol; 1994 Sep; 89(9):1511-4. PubMed ID: 8079929 [TBL] [Abstract][Full Text] [Related]
16. Long term treatment of duodenal ulcer. A review of management options. Bianchi Porro G; Parente F Drugs; 1991 Jan; 41(1):38-51. PubMed ID: 1706986 [TBL] [Abstract][Full Text] [Related]
17. [Role of serum pepsinogen I values in primary duodenal ulcer in childhood]. Scuto S; Ghinelli C; Rollo S; Mori M; Palummeri E Pediatr Med Chir; 1986; 8(6):889-92. PubMed ID: 3601721 [TBL] [Abstract][Full Text] [Related]
18. H2 receptor antagonist or H. pylori eradication? Ahmed W; Qureshi H; Syed S; Alam E; Zuberi SJ J Pak Med Assoc; 1992 Apr; 42(4):81-2. PubMed ID: 1350800 [TBL] [Abstract][Full Text] [Related]
19. Effect of intermittent administration of omeprazole on serum pepsinogens in duodenal ulcer patients and healthy volunteers. Biemond I; Crobach LF; Jansen JB; Lamers CB Br J Clin Pharmacol; 1990 Apr; 29(4):465-72. PubMed ID: 2328194 [TBL] [Abstract][Full Text] [Related]
20. Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders. Ichinose M; Miki K; Furihata C; Kageyama T; Hayashi R; Niwa H; Oka H; Matsushima T; Takahashi K Clin Chim Acta; 1982 Dec; 126(2):183-91. PubMed ID: 7151278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]